Listing 1 - 4 of 4 |
Sort by
|
Choose an application
This Research Topic honors the memory of Prof. Antonius “Ton” G. Rolink (April 19, 1953–August 06, 2017), our colleague, mentor and friend in immunology. It is now over a year since Ton left us. This article collection, authored by many of Ton’s friends and colleagues, reflects the huge contribution to cellular and molecular immunology that work emanating directly from Ton’s own hands and laboratory have made to the understanding of lymphocyte development. Ton’s hard work, expertise, generosity, passion for science and infectious humor were legendary and for all of those lucky enough to have been his colleague, he ensured that science was fun. We take this opportunity of thanking all contributors for submitting their manuscripts; we are sure that Ton would have enjoyed reading and making his own insightful comments on them. In the form of original research and review articles, these papers cover many of Ton’s scientific interests in different aspects of lymphocyte development in mouse and man. In the first section, Development of hematopoietic cells and lymphocytes, Klein et al. describe the accumulation of multipotent hematopoietic progenitors in peripheral lymphoid organs of IL-7xFlt3L double transgenic mice and Pang et al. the role of the transcription factor PU.1 on the development of Common Lymphoid Progenitors. In Early B cell development, Winkler and Mårtensson review the role of the Pre-B cell receptor in B cell development and papers by Hobeika et al. and Brennecke et al. describe models of inducible B cell development. For B cell selection, survival and tolerance, Smulski and Eibel review the role of BAFF and Kowalczyk-Quintans et al. analyse the role of membrane-bound BAFF. The impact of BIM on B cell homeostasis is discussed by Liu et al. The role of the MEK-ERK pathway in B cell tolerance is discussed by Greaves et al. and the transcriptional regulation of germinal center development is reviewed by Song and Matthias. For Hematological diseases, Ghia reviews how studies of B cell development help the understanding of Leukemia development, Kim and Schaniel review how iPS technology helps the understanding of hematological diseases and Hellmann et al. describe development of new therapeutic antibody drug conjugates. Finally, in T cell development, homeostasis and graft vs. host disease, Heiler et al. describe the therapeutic effects of IL-2/anti-IL-2 immune complexes in GvHD, Calvo-Asensio et al. describe the DNA damage response of thymocyte progenitors and Mori and Pieters review the role of Coronin 1 in T cell survival.
T cell development --- B cell selection and survival --- BAFF --- Cytokines --- IPSC --- Leukemia --- T cell survival --- Transcription Factors --- B cell development --- Hematopoietic Stem Cells
Choose an application
Histocytochemistry --- Histochemistry --- Histochimie --- Periodicals. --- Périodiques --- Histochemistry. --- Histocytochemistry. --- Cytochemistry --- Periodicals --- functional cytology --- immunohistochemical analysis techniques. --- cell differentiation and death --- cellular basis of diseases --- biology of cell development and senescence --- functional cell and tissue biology in animals and plants --- Titles of journals. --- Biochemistry --- Histology --- Biology
Choose an application
Histology. Cytology --- General embryology. Developmental biology --- Plant cell culture --- Plant cell development --- Plant cells and tissues --- Plant micropropagation --- Plant tissue culture --- Plants --- Plantes --- Periodicals. --- Periodicals --- Development --- Cellules et tissus --- Culture --- Périodiques --- Développement --- Micropropagation --- Cytology --- Developmental Biology --- periodicals --- Tissue Culture --- Cell Biology --- Développement --- JEX6 --- Cell Biology. --- Developmental Biology. --- Plants. --- 57 --- 576 --- 58 --- Plant --- Botany --- Plant Proteins --- Ethnopharmacology --- Biology, Developmental --- Embryonic and Fetal Development --- Growth and Development --- Cellular Biology --- Biologies, Cell --- Biologies, Cellular --- Biology, Cell --- Biology, Cellular --- Cell Biologies --- Cellular Biologies --- Biological sciences in general --- Cellular and subcellular biology. Cytology --- Agriculture Sciences --- Engineering --- Life Sciences --- Plant Pathology --- Biotechnology --- General and Others --- periodical --- in vitro culture --- USA --- 58 Botany --- 576 Cellular and subcellular biology. Cytology --- Périodiques --- EJBIOLO EJBIOMO EPUB-ALPHA-I EPUB-PER-FT JSTOR-E SPRINGER-E --- Cell development, Plant --- Flora --- Plant kingdom --- Plantae --- Vascular plants --- Vegetable kingdom --- Vegetation --- Wildlife --- In vitro plant propagation --- Micropropagation, Plant --- Plant propagation --- Plant tissues --- In vitro --- Developmental cytology --- Organisms --- Vegetative propagation --- Cells --- Plant anatomy --- Tissues --- Cell culture --- Tissue culture --- Auxology --- 58 Botanie --- Botanie
Choose an application
MicroRNAs (miRs) are small noncoding RNAs that function as post-transcriptional regulators of gene expression and have important roles in almost all biological pathways. Deregulated miR expression has been detected in numerous cancers, where miRs act as both oncogene and tumor suppressors. Due to their important roles in tumorigenesis, miRs have been investigated as prognostic and diagnostic biomarkers and as useful targets for therapeutic intervention. From a therapeutic point of view, two modalities can serve to rectify gene networks in cancer cells. For oncomiRs, a rational means is downregulation through antagomirs. Moreover, observations of the pathological reductions in tumor-suppressive miRs have inspired the concept of “miR replacement therapy” to enhance the amount of these miRs, thereby restoring them to normal levels. However, the clinical applicability of miR-based therapies is severely limited by the lack of effective delivery systems. Therefore, to understand the role of this new class of regulators, we need to identify the mRNA targets regulated by individual miRs as well as to develop specific, efficient, and safe delivery systems for therapeutic miRs.
Breast cancer --- Hypoxia inducible factor 1-alpha (HIF-1α) --- MicroRNA (miRNA) --- miR526b --- miR655 --- Oxidative stress --- Migration --- Cyclooxygenase-2 (COX-2) --- Prostaglandin E2 receptor 4 (EP4) --- PI3K/Akt --- adipokines --- endometrial cancer --- estrogens --- hyperinsulinemia --- insulin --- insulin resistance --- insulin signaling --- insulin-like growth factors --- microRNA --- miRNA --- ovarian cancer --- survival --- prognostic factor --- serum LDH --- blood biomarker --- circulating microRNA --- plasma --- immunotherapy --- immune checkpoint inhibitors --- metastatic melanoma --- hepatocellular carcinoma --- metastasis --- exosome --- bioinformatics analysis --- renal cancer --- RCC --- ccRCC --- meta-analysis --- miRNAs --- normal B-cell development --- B-CLL --- miRNA-transcription factor network --- regulation --- biomarker --- therapy --- prognosis --- diagnosis --- progression --- prediction --- smoking --- non-small cell lung cancer --- methylation --- miR-584-5p --- YKT6 --- snoRNA --- 2′-O-methylation --- pseudouridylation --- malignant melanoma --- cancer stem cell --- stemness --- head and neck squamous cell carcinoma --- colon cancer --- cancer stem cells --- microRNAs --- deformability --- PARP --- replication stress --- targeted therapy --- breast cancer --- circulating biomarkers --- medulloblastoma --- brain tumour --- subgroups --- stem cells --- n/a --- 2'-O-methylation
Listing 1 - 4 of 4 |
Sort by
|